In vivo, Ad-PEDF/Liposome showed stronger inhibited angiogenesis, metastases of B16-F10 melanoma and increased apoptosis, as well as the growth of metastatic tumors than Ad-PEDF used alone. This evidence concerns the gene SERPINF1 and melanoma.